Supplementary Methods 1 from NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (veliparib) Plus Intravenous Irinotecan Administered in Patients with Advanced Solid Tumors
openalex（2023）
Key words
Treatment Guidelines
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined